Q3 2022 EPS Estimates for Livent Co. Lifted by Analyst (NYSE:LTHM)

Livent Co. (NYSE:LTHMGet Rating) – Equities researchers at B. Riley increased their Q3 2022 earnings per share (EPS) estimates for Livent in a research note issued to investors on Thursday, August 4th. B. Riley analyst L. Pipes now forecasts that the company will earn $0.39 per share for the quarter, up from their previous forecast of $0.34. The consensus estimate for Livent’s current full-year earnings is $1.29 per share. B. Riley also issued estimates for Livent’s Q4 2022 earnings at $0.39 EPS, Q1 2023 earnings at $0.38 EPS, Q2 2023 earnings at $0.38 EPS, Q3 2023 earnings at $0.38 EPS and Q4 2023 earnings at $0.44 EPS.

Several other equities analysts have also issued reports on LTHM. Mizuho dropped their price target on Livent from $34.00 to $30.00 and set a “neutral” rating on the stock in a research note on Thursday. TheStreet lowered Livent from a “b” rating to a “c+” rating in a research report on Thursday, July 7th. Cowen raised Livent from a “market perform” rating to an “outperform” rating and upped their target price for the stock from $25.00 to $33.00 in a research report on Wednesday, May 4th. Cowen raised Livent from a “market perform” rating to an “outperform” rating in a research report on Wednesday, May 4th. Finally, Deutsche Bank Aktiengesellschaft lowered their target price on Livent from $29.00 to $24.00 and set a “hold” rating on the stock in a research report on Wednesday, July 6th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $28.67.

Livent Price Performance

Shares of LTHM opened at $24.66 on Friday. Livent has a 52-week low of $19.35 and a 52-week high of $34.61. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.78 and a current ratio of 2.60. The business’s 50 day moving average price is $24.33 and its two-hundred day moving average price is $24.23. The firm has a market cap of $3.99 billion, a PE ratio of 44.84 and a beta of 2.02.

Livent (NYSE:LTHMGet Rating) last issued its quarterly earnings results on Tuesday, August 2nd. The company reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.30 by $0.07. Livent had a return on equity of 14.62% and a net margin of 18.36%. During the same period last year, the firm earned $0.04 EPS.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. BlackRock Inc. grew its stake in Livent by 3.2% in the 1st quarter. BlackRock Inc. now owns 25,674,467 shares of the company’s stock valued at $669,334,000 after purchasing an additional 797,187 shares during the period. Vanguard Group Inc. grew its stake in Livent by 0.6% in the 1st quarter. Vanguard Group Inc. now owns 17,627,545 shares of the company’s stock valued at $459,549,000 after purchasing an additional 109,353 shares during the period. Wellington Management Group LLP grew its stake in Livent by 5.7% in the 1st quarter. Wellington Management Group LLP now owns 7,824,996 shares of the company’s stock valued at $203,997,000 after purchasing an additional 421,082 shares during the period. State Street Corp grew its stake in Livent by 3.8% in the 1st quarter. State Street Corp now owns 5,189,875 shares of the company’s stock valued at $135,300,000 after purchasing an additional 190,369 shares during the period. Finally, Allianz Asset Management GmbH grew its stake in Livent by 35.7% in the 1st quarter. Allianz Asset Management GmbH now owns 2,799,333 shares of the company’s stock valued at $72,979,000 after purchasing an additional 736,174 shares during the period. Institutional investors own 97.33% of the company’s stock.

About Livent

(Get Rating)

Livent Corporation manufactures and sells performance lithium compounds primarily used in lithium-based batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and butyllithium, which is used in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in non-rechargeable batteries and the production of lightweight materials for aerospace applications.

Recommended Stories

Earnings History and Estimates for Livent (NYSE:LTHM)

Want More Great Investing Ideas?

Receive News & Ratings for Livent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livent and related companies with MarketBeat.com's FREE daily email newsletter.